+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Central Nervous System Drugs Market Research Reports

From
Endothelin Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Endothelin Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • March 2025
  • 80 Pages
  • Global
From
From
Guillain-Barré Syndrome (GBS) - Pipeline Insight, 2025 - Product Thumbnail Image

Guillain-Barré Syndrome (GBS) - Pipeline Insight, 2025

  • Clinical Trials
  • March 2025
  • 60 Pages
  • Global
From
Chronic Spinal Cord Injury - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Spinal Cord Injury - Pipeline Insight, 2025

  • Clinical Trials
  • March 2025
  • 60 Pages
  • Global
From
From
From
Amyotrophic Lateral Sclerosis (ALS) - Epidemiology Forecast - 2034 - Product Thumbnail Image

Amyotrophic Lateral Sclerosis (ALS) - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 133 Pages
  • Global
From
Dravet Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Dravet Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • December 2024
  • 60 Pages
  • Global
From
Epilepsy - Pipeline Insight, 2024 - Product Thumbnail Image

Epilepsy - Pipeline Insight, 2024

  • Clinical Trials
  • December 2024
  • 240 Pages
  • Global
From
Rett Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Rett Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • December 2024
  • 80 Pages
  • Global
From
Spinocerebellar Ataxias - Pipeline Insight, 2024 - Product Thumbnail Image

Spinocerebellar Ataxias - Pipeline Insight, 2024

  • Clinical Trials
  • December 2024
  • 60 Pages
  • Global
From
Hypersomnia - Pipeline Insight, 2024 - Product Thumbnail Image

Hypersomnia - Pipeline Insight, 2024

  • Clinical Trials
  • December 2024
  • 60 Pages
  • Global
From
Parkinson's Disease - Epidemiology Forecast - 2034 - Product Thumbnail Image

Parkinson's Disease - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 159 Pages
  • Global
From
Myasthenia Gravis - Epidemiology Forecast - 2034 - Product Thumbnail Image

Myasthenia Gravis - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 143 Pages
  • Global
From
Dementia with Lewy Bodies (DLB) - Epidemiology Forecast - 2034 - Product Thumbnail Image

Dementia with Lewy Bodies (DLB) - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 88 Pages
  • Global
From
From
Sensorineural Hearing Loss (SHL) - Pipeline Insight, 2024 - Product Thumbnail Image

Sensorineural Hearing Loss (SHL) - Pipeline Insight, 2024

  • Drug Pipelines
  • December 2024
  • 80 Pages
  • Global
From
Wilson Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Wilson Disease - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 60 Pages
  • Global
From
Muscarinic Acetylcholine Receptor M1 Antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Muscarinic Acetylcholine Receptor M1 Antagonists - Pipeline Insight, 2024

  • Drug Pipelines
  • November 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Central Nervous System Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs that target the central nervous system. These drugs are used to treat a variety of conditions, including neurological disorders, mental health issues, and pain management. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. The Central Nervous System Drugs market is highly competitive, with companies competing to develop the most effective and safe treatments. Companies in the market are constantly researching and developing new drugs, as well as improving existing treatments. Many of these companies are also involved in clinical trials to test the safety and efficacy of their products. Some of the major companies in the Central Nervous System Drugs market include Pfizer, GlaxoSmithKline, Merck, Novartis, and Johnson & Johnson. These companies are involved in the development and production of a wide range of CNS drugs, including antidepressants, antipsychotics, and anticonvulsants. Show Less Read more